Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

2002
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2007 1
2009 1
2010 2
2011 1
2012 2
2013 3
2014 3
2015 1
2016 1
2018 1
2019 1
2020 1
2021 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area.
Amaddeo G, Brustia R, Allaire M, Lequoy M, Hollande C, Regnault H, Blaise L, Ganne-Carrié N, Séror O, Larrey E, Lim C, Scatton O, El Mouhadi S, Ozenne V, Paye F, Balladur P, Dohan A, Massault PP, Pol S, Dioguardi Burgio M, Vilgrain V, Sepulveda A, Cauchy F, Luciani A, Sommacale D, Leroy V, Roudot-Thoraval F, Bouattour M, Nault JC; Paris Liver Cancer Group. Amaddeo G, et al. JHEP Rep. 2021 Feb;3(1):100199. doi: 10.1016/j.jhepr.2020.100199. Epub 2020 Dec 22. JHEP Rep. 2021. PMID: 33163949 Free PMC article.
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study.
Vitale A, Morales RR, Zanus G, Farinati F, Burra P, Angeli P, Frigo AC, Del Poggio P, Rapaccini G, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Giannini EG, Caturelli E, Chiaramonte M, Trevisani F, Cillo U; Italian Liver Cancer group. Vitale A, et al. Lancet Oncol. 2011 Jul;12(7):654-62. doi: 10.1016/S1470-2045(11)70144-9. Epub 2011 Jun 16. Lancet Oncol. 2011. PMID: 21684210
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F; Italian Liver Cancer group. Farinati F, et al. Eur J Gastroenterol Hepatol. 2009 Oct;21(10):1212-8. doi: 10.1097/MEG.0b013e32831a86f8. Eur J Gastroenterol Hepatol. 2009. PMID: 19465859
Expert consensus on the scheme of pathological diagnosis of primary liver cancer.
Cong WM, Hu XQ, Sun YT, Tan YS, Ji XL, Yun JP, Zhu HG, Guo H, Wang RA, Liu SX, Yin HL, Wang X, Li ZS, Ji Y; Chinese Society of Liver Cancer (CSLC); Chinese Society of Clinical Oncology (CSCO); Liver Cancer Group; Chinese Society of Hepatology; Chinese Pathological Group of Hepatobiliary Tumors and Liver Transplantation. Cong WM, et al. Chin Clin Oncol. 2012 Sep;1(1):12. doi: 10.3978/j.issn.2304-3865.2012.06.02. Chin Clin Oncol. 2012. PMID: 25842070 Free article. No abstract available.
Expert consensus on local ablation therapies for primary liver cancer.
Wu MC, Tang ZY, Ye SL, Fan J, Qin SK, Yang JM, Chen MS, Chen MH, Lv MD, Ma KS, Wu YL, Chen Y, Qian GJ, Lu SC, Zheng JS, Sun WB, Zou YH, Liang HM, Huang ZY, Han XW, Jing X, Pan HM, Jiang TA, Liang P, Ren ZG, Zhang YJ; Chinese Society of Liver Cancer; Chinese Society of Clinical Oncology; Liver Cancer Group; Chinese Society of Hepatology. Wu MC, et al. Chin Clin Oncol. 2012 Sep;1(1):11. doi: 10.3978/j.issn.2304-3865.2012.06.01. Chin Clin Oncol. 2012. PMID: 25842069 Free article. No abstract available.
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M; Italian Liver Cancer Group. Trevisani F, et al. Am J Gastroenterol. 2007 Nov;102(11):2448-57; quiz 2458. doi: 10.1111/j.1572-0241.2007.01395.x. Epub 2007 Jul 7. Am J Gastroenterol. 2007. PMID: 17617210
Years of life that could be saved from prevention of hepatocellular carcinoma.
Cucchetti A, Trevisani F, Bucci L, Ravaioli M, Farinati F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Maida M, Felder M, Morisco F, Gasbarrini A, Gemini S, Foschi FG, Missale G, Masotto A, Affronti A, Bernardi M, Pinna AD; Italian Liver Cancer Group. Cucchetti A, et al. Aliment Pharmacol Ther. 2016 Apr;43(7):814-24. doi: 10.1111/apt.13554. Epub 2016 Feb 11. Aliment Pharmacol Ther. 2016. PMID: 26864152
Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
Brustia R, Bouattour M, Allaire M, Lequoy M, Hollande C, Regnault H, Blaise L, Ganne-Carrié N, Vilgrain V, Larrey E, Lim C, Scatton O, Mouhadi SE, Ozenne V, Paye F, Balladur P, Dohan A, Massault PP, Pol S, Dioguardi Burgio M, Sepulveda A, Cauchy F, Luciani A, Sommacale D, Leroy V, Calderaro J, Roudot-Thoraval F, Nault JC, Amaddeo G; “Paris Liver Cancer Group”. Brustia R, et al. Ann Hepatol. 2023 Nov-Dec;28(6):101141. doi: 10.1016/j.aohep.2023.101141. Epub 2023 Jul 17. Ann Hepatol. 2023. PMID: 37468096 Free article.
24 results